Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Verapamil hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for verapamil hydrochloride and what is the scope of verapamil hydrochloride freedom to operate?

Verapamil hydrochloride
is the generic ingredient in seven branded drugs marketed by Glenmark Generics, Mylan, Recro Gainesville, Luitpold, Gd Searle Llc, Actavis Elizabeth, Pliva, Sandoz, Watson Labs, Exela Pharma Scs Llc, Sun Pharm Inds Inc, Ivax Sub Teva Pharms, Marsam Pharms Llc, Hospira, Warner Chilcott, Abraxis Pharm, Intl Medication, Pfizer, Par Pharm, Cadila Pharms Ltd, Apotex Corp, Heritage Pharms Inc, Mutual Pharm, Mt Adams, Bedford, Sun Pharm Inds, Solopak, and Smith And Nephew, and is included in sixty-two NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Verapamil hydrochloride has eighteen patent family members in sixteen countries.

There are sixteen drug master file entries for verapamil hydrochloride. Thirty-eight suppliers are listed for this compound.

Summary for Generic Name: verapamil hydrochloride

Drug Master File Entries: see list16
Suppliers / Packagers: see list38
Bulk Api Vendors: see list64
Clinical Trials: see list1,018
Patent Applications: see list3,449
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:verapamil hydrochloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
verapamil hydrochloride
TABLET, EXTENDED RELEASE;ORAL019152-001Dec 16, 1986ABRXYesYes► Subscribe► Subscribe
Abraxis Pharm
verapamil hydrochloride
INJECTABLE;INJECTION070348-001May 1, 1986DISCNNoNo► Subscribe► Subscribe
verapamil hydrochloride
TABLET, EXTENDED RELEASE;ORAL019152-003Mar 6, 1991ABRXYesYes► Subscribe► Subscribe
Ivax Sub Teva Pharms
verapamil hydrochloride
TABLET, EXTENDED RELEASE;ORAL073568-002Oct 10, 1997ABRXNoNo► Subscribe► Subscribe
verapamil hydrochloride
INJECTABLE;INJECTION070617-001Nov 12, 1985DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus